Selected Publications

1. Fasouli ES and Katsantoni E. JAK-STAT in Early Hematopoiesis and Leukemia. Front. Cell Dev. Biol. 2021, 9:669363.
    
2. Nanou A, Toumpeki C, Fanis P, Bianchi N, Cosenza LC, Zuccato C, Sentis G, Giagkas G, Stephanou C, Phylactides M, Christou S, Hadjigavriel M, Sitarou M, Lederer CW, Gambari R, Kleanthous M, Katsantoni E. Sex-specific transcriptional profiles identified in β-thalassemia patients. Haematologica. 2020 Aug 13: haematol.2020.248013.
    
3. Katsantoni E. Omics Studies in Hemoglobinopathies. Mol Diagn Ther. 2019 Apr;23(2):223-234.
    
4. Nanou A, Toumpeki C, Lavigne MD, Lazou V, Demmers J, Paparountas T, Thanos D, Katsantoni E. The dual role of LSD1 and HDAC3 in STAT5-dependent transcription is determined by protein interactions, binding affinities, motifs and genomic positions. Nucleic Acids Res. 2017 Jan 9;45(1):142-154. Epub 2016 Sep 19.
    
5. Theodorou M, Speletas M, Mamara A, Papachristopoulou G, Lazou V, Scorilas A, Katsantoni E. Identification of a STAT5 target gene, Dpf3, provides novel insights in chronic lymphocytic leukemia. PLoS One. 2013 Oct 14;8(10):e76155.
    
6. Katsantoni E. Protein complexes and target genes identification by in vivo biotinylation: the STAT5 paradigm. Sci Signal. 2012 Oct 30;5(248):pt13. doi: 10.1126/scisignal.2003622.